Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6951
PUT
Radware
RDWR
$1.18B
| $1.01M | ﹤0.01% |
44,800
+28,500
| +175% | +$652K |
|
6952
CALL
i3 Verticals
IIIV
$291M
| $1.01M | ﹤0.01% |
43,800
-62,900
| -59% | -$1.48M |
|
6953
CALL
ClearPoint Neuro
CLPT
$463M
| $1.01M | ﹤0.01% |
65,600
+37,600
| +134% | +$487K |
|
6954
CALL
EverQuote
EVER
$864M
| $1.01M | ﹤0.01% |
50,400
-11,800
| -19% | -$223K |
|
6955
Zumiez
ZUMZ
$305M
| $1.01M | ﹤0.01% |
52,550
-56,725
| -52% | -$1.21M |
|
6956
CALL
XPEL
XPEL
$1.37B
| $1.01M | ﹤0.01% |
25,200
-16,300
| -39% | -$696K |
|
6957
Viavi Solutions
VIAV
$10.2B
| $1.01M | ﹤0.01% |
99,651
+66,767
| +203% | +$659K |
|
|
SKE
6958
PUT
Skeena Resources
SKE
$3.9B
| $1.01M | ﹤0.01% |
115,400
-900
| -0.8% | -$8.19K |
|
6959
Levi Strauss
LEVI
$8.47B
| $1.01M | ﹤0.01% |
58,161
-13,972
| -19% | -$247K |
|
6960
PUT
Advanced Energy
AEIS
$12.6B
| $1.01M | ﹤0.01% |
8,700
+4,400
| +102% | +$495K |
|
|
SMCX
6961
CALL
Defiance Daily Target 2X Long SMCI ETF
SMCX
$237M
| $1.01M | ﹤0.01% |
12,803
+12,610
| +6,534% | +$2.38M |
|
6962
Red River Bancshares
RRBI
$670M
| $1.01M | ﹤0.01% |
18,630
+5,381
| +41% | +$298K |
|
6963
PUT
Keros Therapeutics
KROS
$210M
| $1.01M | ﹤0.01% |
63,500
+58,200
| +1,098% | +$3.02M |
|
6964
PUT
Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X ETF
DRIP
$97.9M
| $1M | ﹤0.01% |
9,220
+4,670
| +103% | +$488K |
|
|
MMKT
6965
Texas Capital Government Money Market ETF
MMKT
$72.7M
| $1M | ﹤0.01% |
+10,030
| New | +$1.01M |
|
|
HTB
6966
HomeTrust Bancshares
HTB
$794M
| $1M | ﹤0.01% |
29,811
-2,180
| -7% | -$76.6K |
|
6967
Nuveen Enhanced Yield US Aggregate Bond ETF
NUAG
$97.4M
| $1M | ﹤0.01% |
48,661
+32,953
| +210% | +$693K |
|
6968
PUT
Emergent Biosolutions
EBS
$239M
| $1M | ﹤0.01% |
105,000
-66,400
| -39% | -$609K |
|
|
PENG
6969
CALL
Penguin Solutions Inc
PENG
$2.99B
| $1M | ﹤0.01% |
52,300
+28,100
| +116% | +$513K |
|
6970
Davis Select US Equity ETF
DUSA
$1.27B
| $1M | ﹤0.01% |
+23,833
| New | +$1.02M |
|
6971
PUT
Universal Corp
UVV
$1.11B
| $1M | ﹤0.01% |
18,300
+10,700
| +141% | +$573K |
|
6972
Federal Agricultural Mortgage
AGM
$2.49B
| $1M | ﹤0.01% |
5,094
+4,419
| +655% | +$877K |
|
6973
CALL
Essential Utilities
WTRG
$11.5B
| $1M | ﹤0.01% |
27,600
+8,400
| +44% | +$326K |
|
6974
CALL
Legend Biotech
LEGN
$4.25B
| $1M | ﹤0.01% |
30,800
+1,500
| +5% | +$62.1K |
|
6975
Franklin Investment Grade Corporate ETF
FLCO
$555M
| $1M | ﹤0.01% |
47,503
-8,439
| -15% | -$181K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.